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The HERG K channel has very unusual kinetic be-
havior that includes slow activation but rapid inactiva-
tion. These features are critical for normal cardiac re-
polarization as well as in preventing lethal ventricular
arrhythmias. Mutagenesis studies have shown that the
extracellular peptide linker joining the fifth transmem-
brane domain to the pore helix is critical for rapid inac-
tivation of the HERG K channel. This peptide linker is
also considerably longer in HERG K channels, 40
amino acids, than in most other voltage-gated K chan-
nels. In this study we show that a synthetic 42-residue
peptide corresponding to this linker region of the HERG
K channel does not have defined structural elements in
aqueous solution; however, it displays two well defined
helical regions when in the presence of SDS micelles.
The helices correspond to Trp585–Ile593 and Gly604–
Tyr611 of the channel. The Trp585–Ile593 helix has distinct
hydrophilic and hydrophobic surfaces. The Gly604–
Tyr611 helix corresponds to an N-terminal extension of
the pore helix. Electrophysiological studies of HERG
currents following application of exogenous S5P pep-
tides show that the amphipathic helix in the S5P linker
interacts with the pore region of the channel in a voltage-
dependent manner.
HERG (human ether-a-go-go related gene) encodes the pore-
forming -subunit of the rapid delayed rectifier potassium
channel, IKr (1). The channel is an important contributor to
repolarization of the cardiac action potential (1–3). Further-
more, mutations in HERG cause congenital long QT syndrome
type 2 (4), which results in a markedly increased risk of ven-
tricular arrhythmias and sudden cardiac death (5, 6). A wide
range of drugs that block the HERG K channel also result in
drug-induced long QT syndrome, the most common cause of
serious drug-induced arrhythmia and death (7, 8). Therefore,
there is considerable interest in gaining a better understanding
of the structure and structure-function relationships in the
HERG K channel.
HERG is a member of the family of voltage-gated K chan-
nels (VGK)1 that contain six transmembrane domains, denoted
by S1–S6, and a pore helix that is interposed between S5 and
S6. The positively charged S4 acts as the voltage sensor for
activation (9). Unlike other members of the VGK family, the
HERG channel also undergoes very rapid voltage-dependent
inactivation and recovery from inactivation (1, 10–12). Conse-
quently the HERG K channel functions as an inward rectifier,
i.e. it passes little current at depolarized potentials but large
currents during the terminal repolarization phase of the car-
diac action potential (13, 14). This rapid inactivation is also
critical for the role of the channel in suppressing arrhythmias
initiated by ectopic electrical excitation (11, 15).
Inactivation of the HERG K channel results from confor-
mational changes in the outer pore region of the channel (11,
12, 16–19) and involves so-called “collapse of the pore” (20).
The pore region of HERG, including the pore helix, a selectivity
filter, and S6, is highly homologous to that of other members of
the VGK family (8, 9) as well as to the bacterial K channel
KcsA (21, 22). This feature has enabled homology models of
HERG K channels to be constructed based on the KcsA struc-
ture (21). However, the extracellular loop connecting the pore
helix to the top of S5 (S5P loop) in HERG is very different from
that in other VGK family members. First, the S5P loop in
HERG is about 40 amino acids long, compared with 10–15 in
most other members of the VGK family (9, 23) (also see Fig. 1).
Second, many mutations in the S5P loop disrupt the inactiva-
tion process in HERG (19, 23, 24). Third, toxins that bind to the
S5P loop of other VGK channels, e.g. agitoxin and charybdo-
toxin (25), do not bind to HERG. Conversely, toxins that bind to
this region of HERG, e.g. ErgToxin and BeKm-1, do not bind to
other members of the VGK family (26, 27). The S5P loop of
HERG therefore appears to be a critical region of the protein,
but at present there is little specific information known about
its three-dimensional structure.
Following the determination of the structure of a number of
prokaryotic K channels (22, 28–30), great progress has been
made in the understanding of the spatial arrangement of
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amino acid side chains in the pore region of K channels.
Nevertheless, the crystallization and determination of the
structure of ion channels remains a tremendously difficult task
(31), and to date no structures of mammalian ion channels have
been determined (32). For this reason, CD spectropolarimetry
(33, 34) and NMR spectroscopy (35) have been used to gather
information on the structure of ion channels and/or domains.
Although NMR spectroscopy has limitations in terms of the
size of proteins whose structure can be determined, it has the
advantage of permitting the determination of structures in a
lipid environment (36), thereby eliminating the problems asso-
ciated with crystallization of membrane proteins (31).
In this study we have used a combination of CD spectropo-
larimetry, two-dimensional 1H NMR spectroscopy, and electro-
physiology to investigate the structure and function of the S5P
linker of the HERG K channel. Our findings show that the
S5P linker contains an amphipathic -helix. Exogenous appli-
cation of the S5P peptide fragment or a peptide corresponding
to the amphipathic -helix results in altered ionic selectivity
and disruption of inactivation of the HERG K channel. These
results suggest that the amphipathic -helix in S5P is critical
for inactivation of HERG K channels.
EXPERIMENTAL PROCEDURES
Peptide Preparation—The peptides were synthesized on a 0.50-mmol
scale using O-(Benzotriazol-1-yl)-N,N,N,N-tetramethyluronium
hexafluorophosphate activation of Boc-amino acids with in situ neutral-
ization chemistry, as previously described (37). The syntheses were
performed on Boc-Tyr(2BrZ)-OCH2-Pam resin using standard amino
acid side chain protection, except that methionine residues at positions
5 and 10 were replaced by the isosteric norleucine residue to prevent
adventitious oxidation of the peptide. This step is necessary to stabilize
the synthetic peptide and is not expected to affect the peptide confor-
mation (37). Each residue was reacted for 10 min, and coupling effi-
ciencies were determined by the quantitative ninhydrin reaction. Prior
to a standard HF cleavage (10 ml of p-cresol:HF 1:9, 0 °C, 60 min) and
workup, the N-terminal Boc protecting group was removed (100% tri-
fluoroacetic acid), followed by formyl group removal (1.5 ml of ethanol-
amine in 25 ml of N,N-dimethylformamide and 5% water, twice for 30
min).
Three peptides were synthesized in this study: a 42-residue peptide
corresponding to the S5P linker of HERG (residues Ala570–Tyr611), to
which we refer as the S5P peptide; a 42-residue peptide in which the
putative amphipathic helix corresponding to residues Gly584–Lys595
(23) was replaced with a GGGSGGGSGGGS linker, to which we refer as
the del-helix peptide; and finally a 19-residue peptide corresponding to
the putative amphipathic helix and four residues at each end (i.e.
Ser581–Ser599 of wild type HERG), to which we refer as the helix
peptide.
The NMR spectroscopy sample was prepared by dissolving 2.6 mg of
the S5P peptide in400 l of 90% H2O, 10% D2O (v/v) containing 12 mg
of SDS-d25 (100 mM; the critical micellar concentration for SDS is 8
mM) in a 5-mm outer diameter susceptibility-matched microcell (Shi-
gemi, Tokyo, Japan). This resulted in a peptide concentration of 1.4 mM
and pH 3.3.
NMR Spectroscopy—NMR spectroscopy experiments were performed
on a Bruker Avance-600 DRX spectrometer with a 5-mm 1H inverse
probe with operating temperatures of 20, 30, and 37 °C. The homo-
nuclear two-dimensional experiments that were performed included
double quantum-filtered correlation spectroscopy (38) with a phase
cycle modified for fast recycle times (38), total correlation spectroscopy
(39) with MLEV spin-lock periods of 35 and 90 ms, and nuclear Over-
hauser enhancement spectroscopy (NOESY) (40) with mixing times of
200 and 300 ms. All two-dimensional spectra were acquired using time
proportional phase detection (41). In double quantum-filtered correla-
tion spectroscopy and NOESY experiments, water signal suppression
was achieved by low power irradiation at the water resonance during
the relaxation delay (1.3 s) and during the mixing period in NOESY
experiments. In total correlation spectroscopy experiments, the water
signal was suppressed using the WATERGATE gradient module (42).
All of the spectra were processed using XWIN-NMR software (Bruker,
Karlsru¨he, Germany).
Structure Calculations—Analyses of two-dimensional spectra were
carried out using the XEASY program (43). Distance constraints were
obtained from cross-peak volumes in the NOESY spectra recorded at
30 °C with a mixing time of 200 ms. This yielded 416 nonredundant
upper distance constraints. An additional 14 distant constraints for
hydrogen bonding were obtained from a hydrogen-deuterium exchange
experiment. No  dihedral angle constraints were used in the structure
calculations because backbone amide peaks were too broad, probably
because of conformational averaging of the peptide structure when in
the presence of SDS micelles. The simulated annealing protocol in the
torsion angle dynamics program DYANA (44) was used to obtain pre-
liminary three-dimensional structures prior to refinement. Of the 1600
structures generated in DYANA, 40 of the “best” structures, with the
lowest NOE violations, were chosen for refinement using the standard
simulated annealing script in CNS (45). In this refinement process, the
high temperature dynamics and cooling cycle were performed in Car-
tesian space. Analysis of the ensemble of S5P structures was also
carried out using PROMOTIF, a program that identifies structural
motifs in proteins (46). The figures were generated using MOLMOL
(47).
Circular Dichroism Spectropolarimetry—CD spectropolarimetry
spectra were recorded on a Jasco J-720 spectropolarimeter equipped
with a Neslab RTE-111 temperature controller. CD spectropolarimetry
data were collected using a 1-mm cuvette over the wavelength range
190–250 nm and with a resolution of 0.5 nm, a bandwidth of 1 nm, and
a response time of 1 s. Final spectra were the sums of three scans
accumulated at a speed of 20 nm/min and were base line-corrected.
Peptide concentration was 0.45 mg/ml for the S5P peptide or 0.15 mg/ml
for the del-helix and helix peptides, in 10 mM sodium phosphate, pH 3.0
and 7.0, with or without the addition of 100 mM SDS. The data are
presented as molar ellipticity [], where []  /(10  c  l) and  is
ellipticity (mdeg), c is the molar concentration of the sample (mol/liter),
and l is the pathlength in cm.
FIG. 1. A, alignment of the S5, pore he-
lix, and selectivity filter regions of
Shaker, KcsA and HERG. Gray shading
indicates S5 (Shaker and HERG) or outer
helix (KcsA) and the pore helices. The
asterisks indicate methionine residues
that were replaced with norleucine in the
synthesized peptide to simplify structure
assignment (see text for details). Residues
in HERG shown in bold type indicate the
peptide that was synthesized in this
study. The inset shows a cartoon of a
HERG K channel subunit, with the re-
gion of interest highlighted by gray shad-
ing and bold lines. B, alignment of the
region surrounding the amphipathic helix
(shaded region) of HERG with other mem-
bers of the ERG/EAG/ELK family of K
channels. Residues in white with black
shading indicate hydrophobic residues
conserved in all eight members of the
ERG/EAG/ELK family.
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Electrophysiology—Chinese hamster ovary (CHO) cells stably trans-
fected with HERG K channels were maintained in culture using Dul-
becco’s modified Eagle’s medium/Ham’s F-12 medium (Invitrogen) with
5% fetal bovine serum, as previously described (48). CHO cells were
plated on 13-mm glass coverslips 48–72 h prior to patch clamp analysis.
The coverslips were then placed in a 0.5-ml perfusion chamber mounted
on the stage of a Nikon Eclipse TE200 inverted microscope. The cells
were superfused with normal Tyrode solution that contained 130 mM
NaCl, 4.8 mM KCl, 0.3 mM KH2PO4, 0.35 mM NaH2PO4, 1.8 mM CaCl2,
1.0 mM MgCl2, 10 mM HEPES, pH adjusted to 7.4 with NaOH. In the
Na-free external solution NaCl was replaced with N-methyl-D-gluca-
mine (NMDG)-Cl, and the NaH2PO4 was omitted. The cells were
patched using micropipettes fabricated from thin walled borosilicate
glass (Vitrex Microhematocrit tubes, Modulohm I/S, Denmark) with a
horizontal pipette puller (model P-87; Sutter Instrument Co.). The
pipette solution contained 120 mM potassium gluconate, 20 mM KCl, 1.5
mM MgATP, 5 mM EGTA, 10 mM HEPES, pH adjusted to 7.4 with KOH.
The permeability ratio of K/Na, , was calculated from the reversal
potential measured in standard Tyrode solution using the following
constant field equation,
Erev RT/F ln[([K]o  [Na]o)/([K]i  [Na]i) (Eq. 1)
and assuming that [K]i  145 mM and [Na
]i  5 mM.
Conventional whole cell voltage clamp recordings were performed
using an Axopatch 200B amplifier interfaced with a Digidata 1200 A/D
converter operated using pClamp software (Axon Instruments, Foster
City, CA). All of the experiments were performed at room temperature.
Whole cell capacitance was determined from capacitative transient
decay in current recordings following voltage steps  10 mV from the
holding potential, and at least 80% series resistance compensation was
achieved in all of the reported experiments. The protocols used in the
specific experiments are described in the figure legends. In all protocols
a 20-ms duration 20 mV step from the holding potential of 80 to 100
mV was applied at the start of each sweep to enable off-line leak
correction. We assumed that the leak was linear in the voltage range
120 to 40 mV. Data analysis was performed using the Clampfit
module of the PClamp software. The data are expressed as the means
S.E. for n experiments, and analysis of variance was performed using
Microsoft Excel. A p value of 0.05 was considered significant.
For electrophysiology experiments the peptides were prepared as 0.5
mM stock solutions in either normal Tyrode or Na-free external solu-
tion, and aliquots were stored at 20 °C. Once thawed aliquots were
stored at 4 °C for up to 2 weeks. The aliquots were diluted as required
on the day of experiment. The peptides were applied to cells using a
picospritzer II (Intracell, Cambridge, UK) to ensure rapid application
(typically less that 20 ms) and minimize the amount of peptide used in
each experiment. A new coverslip was used for each experiment to
ensure no residual contamination of cells with peptides.
Analysis of Peptide Binding Data—Apparent on rates, () and off
rates (k1) for peptide binding were obtained by fitting single exponen-
tial functions to the data for onset of current block and recovery of
current following washout of the peptide. The on rate (k1) was calcu-
lated using the formula,
  [peptide]k1  k1 (Eq. 2)
To obtain the time constant for the apparent on rate of peptide binding
at negative potentials, it was necessary to correct for channel deactiva-
tion (see Fig. 9). We assumed that the rate of binding of the peptide to
the channel was independent of the rate of deactivation, and therefore,
Iobs  Aexp(t/obs)  C  Aexp(t/deact)exp(t/on)  C (Eq. 3)
where A and C are constants, obs is the observed single exponential
time constant measured from the rate of change in current following
addition of the peptide, deact is the time constant of deactivation (esti-
mated from the single exponential fit to the current recorded in the
absence of peptide), and on is the apparent time constant for peptide
binding, i.e. on  1/.
RESULTS
Circular Dichroism Spectropolarimetry—Far-UV CD spec-
tropolarimetry spectra of the S5P HERG peptide in 10 mM
sodium phosphate buffer with and without 100 mM SDS at
20 °C and pH 3.0 are shown in Fig. 2. The large minimum
between 195 and 200 nm and ellipticity close to zero at 222 nm
for the S5P peptide in aqueous solution (thin line) indicates
that the peptide does not have a well defined secondary struc-
ture under these conditions. This outcome prompted our inves-
tigation of the structural properties of the peptide under mem-
brane-like conditions. A dramatic change in the CD
spectropolarimetry spectral profile was observed upon addition
of 100 mM SDS (Fig. 2, thick line); positive ellipticity was
observed between 190 and 195 nm, the position of the mini-
mum shifted to 205 nm, and a marked shoulder was present at
222 nm. This indicated that the S5P peptide contains helical
elements in the micellar environment at pH 3.0. Similar CD
spectropolarimetry profiles were obtained at pH 7.0 (also see
Fig. 10) and over the temperature range 20–30 °C. NMR spec-
troscopy experiments were therefore performed at a pH level of
3 to facilitate data collection.
NMR Spectroscopy—The two-dimensional NOESY spectrum
of the S5P peptide in aqueous solution at 25 °C had only a few
very weak cross-peaks, suggesting that the peptide had a flex-
ible, predominantly random coil structure (data not shown)
that was consistent with the CD spectropolarimetry data (Fig.
2). The number and intensity of cross-peaks in the two-dimen-
sional NOESY spectrum improved markedly upon the addition
of 100 mM SDS. The appearance of amide-amide cross-peaks
indicated that the peptide contained some helical structure
when in the presence of SDS micelles (Fig. 3), in accordance
with the CD spectropolarimetry results.
Assignments of proton resonances from the S5P peptide were
made using standard methods (49) of analyzing two-dimen-
sional total correlation spectroscopy and NOESY spectra. The
cross-peaks were generally broader than those in aqueous so-
lution, presumably because of the increased correlation time of
the peptide and possible conformational averaging and slow
exchange between conformations. At 20 °C, NOE cross-peaks
were too broad to analyze and in several instances overlapped
with other cross-peaks, especially in the “fingerprint” region.
Increasing the temperature brought about significant narrow-
ing of the cross-peaks; however, some NOE cross-peaks became
less intense, and a few disappeared. The NOESY spectrum
obtained at 30 °C was seen to be the best for resonance assign-
ment and structural calculations, but where possible, spectra
obtained at 20 °C or 37 °C were used to resolve peaks that
overlapped at 30 °C (see Table S1 in the supplementary data).
Before doing the structure calculations, the chemical shift
values obtained for C protons were analyzed to provide infor-
mation on possible secondary structure present in the peptide.
For this we used the chemical shift index method of Wishart et
al. (50). A prominent grouping of chemical shift deviations
below 0.1 ppm for most residues between 16 and 22 implied a
FIG. 2. Comparison of the far-UV CD spectropolarimetry spec-
tra of the HERG S5P loop peptide in 10 mM phosphate, pH 3.0
(thin line), and in 10 mM phosphate, 100 mM SDS, pH 3.0 (thick
line). In aqueous solution, the peptide displays a signal indicative of an
unstructured protein, with a large minimum between 195 and 200 nm.
In the membrane mimic environment, the peptide assumes some helical
structure, displaying the characteristic signals of positive ellipticity
between 190 and 195 nm and negative minima at 205 and 222 nm.
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prominent helix in this part of the molecule (Fig. 4). It is also
possible that a short helix is present in the region formed by
residues 39–41 because they form a small cluster of three with
low chemical shift deviations. The absence of a group of resi-
dues with chemical shift deviations greater than 0.1 ppm
indicated that no -sheet structure is expected for the S5P
HERG peptide. The rest of the S5P HERG peptide, residues
1–15 and 23–38, is likely to be flexible or in random
conformations.
In addition to the presence of significant amide-amide NOE
connectivities, the two-dimensional NOESY spectrum of S5P
showed many medium range connectivities between residues
14–24 and 38–42 (Fig. 4). This supported the proposal that
these regions formed helices as indicated by the CD spectropo-
larimetry spectra (Fig. 2) and chemical shift indices (Fig. 4). No
long range NOEs were detected, implying that the S5P peptide
does not have a well defined tertiary structure. A total of 416
distance (upper limit) constraints (of which 74 were medium
range) were obtained from the 200-ms NOESY spectrum (see
Table S2 in the supplementary data); the constraints were used
in structure calculations using DYANA and CNS (see “Exper-
imental Procedures”). The best 20 structures, namely those
with the lowest penalty values, were considered to be repre-
sentative of the structure and were therefore used in the fig-
ures shown here.
Structural Fold—Comparison of the 20 best S5P structures
showed that S5P did not have a distinct three-dimensional fold
in SDS micelles. However, two regions in the peptide were well
defined; this was indicated by their relatively low root mean
square deviation values, with respect to the local mean struc-
ture. These were regions defined by residues 14–24 and 35–42
that had mean backbone root mean square deviations of 0.31
and 0.23 Å, respectively (see Table S2 in the supplementary
data). These two well defined regions encompassed all residues
displaying medium range NOE values and were predicted to be
helical by the CSI analysis (Fig. 4). Also, PROMOTIF analysis
(46) of the ensemble of S5P structures predicts that the regions
defined by residues 16–25 and 35–42 form -helices in the
presence of SDS micelles. Fig. 5A shows the superpositions of
20 structures on to the backbone of the well defined region
defined by residues 14–24. The rest of the molecule, except for
the region defined by residues 35–42, appears disordered (Fig.
5B). It should also be noted that because the region defined by
residues 24–35 is disordered (represented by a dashed line in
Fig. 5B), it is not possible to define the spatial relationship
between the two helical regions. The conclusion that the re-
gions defined by residues 1–14 and 24–35 lacked defined struc-
tures in solution was based on the absence of medium and long
range NOEs.
In the KcsA structure (22), the ends of the extracellular loop
that corresponds to S5P in HERG, (i.e. Ala50 and Tyr62 in KcsA)
are close together, being separated by only 11 Å. We at-
tempted to constrain the ends of the S5P peptide by introducing
a “dummy” distance constraint of 10.9 Å between the backbone
C of Ala1 and that of Tyr42 in the NMR spectroscopy structure
calculation. This could have provided useful insights into the
three-dimensional fold of the peptide and also information
about the relative orientation of the amphipathic -helix (see
below) with respect to rest of the molecule. However, the cal-
culation failed to indicate a distinct structural fold.
The Amphipathic Helix—Detailed analysis of the first well
defined region showed that it was an amphipathic helix, with
the side chains of Trp16, Leu17, Leu20, and Ile24 forming the
FIG. 3. Amide region of 200-ms NOESY spectrum of S5P pep-
tide in 100 mM SDS at pH 3.3 and 30 °C. Presence of nondiagonal
NOESY cross-peaks in this region suggests turn-like or helical confor-
mation in the molecule. The intense NOESY cross-peaks in the spec-
trum are labeled with two residue numbers corresponding to the two
amide protons that are close in space.
FIG. 4. Summary of NMR spectroscopy data for secondary
structure prediction in S5P peptide in 100 mM SDS. The two
residues denoted by X are norleucines, which replaced methionines.
Slowly exchanging backbone amide protons are indicated by circles;
NOE connectivities are represented by shaded horizontal bars whose
thickness are proportional to the observed NOE intensities; the chem-
ical shift index (i.e. H chemical shift deviations from random coil
values (50)) are indicated by vertical bars.
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hydrophobic face and the side chains of His18, Asn19, Asp22, and
Gln23 defining a hydrophilic edge. (Fig. 5). The side chains of
residues 16–20 were well defined, with root mean square de-
viation values of 0.23 Å when their side chain heavy atoms
were superimposed on each other (see Table S2 in the supple-
mentary data). There were numerous medium range NOEs
between the Trp16 aromatic side chains and those of Ile14,
Leu17, and Leu20; this helped to define the conformation of the
hydrophobic region of the molecule, placing Trp16 as the center
of this site.
Role of Amphipathic Helix in Inactivation—The unusual ki-
netics of HERG K channels, viz. slow activation/deactivation
and rapid inactivation/recovery from inactivation, are illus-
trated in Fig. 6A. Depolarizations to 40 mV cause HERG
channels to open slowly and then inactivate rapidly, resulting
in a relatively small current flow. Subsequent repolarization to
120 mV results in rapid recovery from inactivation and hence
a large increase in inward current followed by a slower decay in
the current as the channels deactivate. To investigate whether
exogenous application of the S5P peptide would have any effect
on full-length HERG channels, we superfused cells with 1 M
S5P peptide, and the membrane was depolarized from 80 to
40 mV for 0.5 s followed by a hyperpolarization to 120 mV
for 1 s, and the protocol repeated every 5 s. Application of the
42-residue S5P peptide caused a reversible suppression of
HERG current (Fig. 6, B and C). Application of 1 M S5P
peptide to CHO cells transfected with HEAG or rELK2 chan-
nels resulted in no reduction in current (data not shown).
The apparent on rates and off rates for peptide binding to the
channels were obtained by fitting single exponential functions
to the data for onset of current block and recovery of current
following washout of the peptide. In the example illustrated in
Fig. 6C, the time constants for peptide binding and wash-off
were 17.8 s (  0.056 s1) and 53.7 s (k1  0.019 s
1),
respectively. The mean values obtained from four separate cells
were   0.045  0.007 s1 and k1  0.024  0.005 s
1 (n 
4). Substituting values for  and k1  into Equation 2 gave an
on rate (k1) of 2.1  0.4  10
4 M1 s1, and the dissociation
constant for peptide binding (KA  k1/k1) was 1.1  0.4 M
(n  4).
To investigate further the binding of the S5P peptide to
HERG channels, we used a picospritzer to rapidly apply pep-
tides and minimize the amount of peptide used in each exper-
iment. First we investigated the dose response of the effect of
S5P peptide by applying the peptide at doses ranging from 0.1
to 100 M (Fig. 6D) using the same voltage protocol as used in
Fig. 6A. The IC50 for inhibition of the tail current at 120 mV
measured from the dose-response curve was 1.9 M (Fig. 6D).
This value is similar to that measured from the on and off rates
for 1 M S5P, i.e. 1.1 M.
To investigate the voltage dependence of the effect of S5P
peptide on HERG channels, we used a voltage protocol where
within each sweep channels were first activated by stepping to
40 mV for 500 ms and then stepped to a test voltage in the
range 30 to 110 mV followed by a 120 mV step for 800 ms
to fully deactivate the channels. The protocol was then re-
peated with peptide rapidly applied for 1 s during the test
voltage step (Fig. 7A). Based on the on rate for S5P peptide
binding to HERG K channels calculated above, we used 100
M S5P peptide in these experiments so as to achieve 	90%
binding within 1 s of application.
The effect of rapid application of 100 M S5P peptide was
voltage-dependent. For example, application of S5P peptide
caused an increase in outward current at 30 mV (Fig. 7A,
solid arrows) but a significant decrease in the current at 50
mV (Fig. 7A, dotted arrows). In the protocol illustrated in Fig.
7A, we waited 60 s between sweeps to ensure that the effect of
the peptide had washed out (also see Fig. 7B). The traces in Fig.
7B show the average ( S.E.) current recorded during five
successive sweeps at 60-s intervals where the test potential
was 70 mV for all five sweeps. Both the control currents (Fig.
7B, thin line) and currents recorded during application of the
S5P peptide (Fig. 7B, thick line) were superimposable. This
illustrates two important points. First, during the 60-s inter-
sweep interval, the effect of the peptide was completely washed
out, and second, the effect of the peptide was very reproducible.
Also of note from Fig. 7B is that in the presence of the S5P
peptide the current recorded at 70 mV reversed from an
outward current to a small inward current, suggesting that
application of the peptide altered the selectivity of the channel
(see below).
Examples of currents recorded at voltages in the range 30
to 110 mV (in 10 mV steps) using the voltage protocol illus-
trated in Fig. 7A are illustrated in Fig. 8. At positive potentials
(panels a–c) application of the peptide resulted in an increase
in current that was maintained for the duration of application
of the peptide. At voltages in the range 0 to 20 mV (panels
d–f), there was an initial increase in current followed by a
slower decline in current during application of the peptide. In
the voltage range 30 to 60 mV (panels g–j), there was a
rapid decrease in current during application of the peptide. The
most dramatic effects, however, occurred at 70 (panel k) and
80 mV (panel l) where the peptide caused a reversal in cur-
rent flow. This suggests that the channel has lost its selectivity
for K over Na (the only other cation present at significant
concentrations in the extracellular solution). At progressively
more negative potentials it became difficult to discern an effect
of the peptide. From the data in Fig. 6, however, we know that
the peptide can inhibit the channel at 120 mV; therefore the
lack of apparent effect at the most negative voltages in Fig. 8 is
presumably because the rate of channel deactivation is as fast
if not faster than the rate of peptide binding to the channel at
these voltages.
To quantify the effect of the S5P peptide on HERG channels,
we analyzed the rates of change in current magnitude following
the addition of the peptide (i.e. the apparent on rates; Fig. 9, A
FIG. 5. NMR spectroscopy structure of S5P peptide in 100 mM
SDS micelles. A, region defined by residues 14–25 of ensemble of 20
structures superimposed over the backbone atoms of residues 14–24 of
the local mean structure. B, the whole S5P peptide showing the helices
at the center and the N-terminal end of the molecule. The dashed lines
(residues 1–14 and 25–34) indicate that these regions did not have a
defined structure. Hydrophobic sidechains are shown in yellow and
hydrophilic sidechains are shown in blue. The diagrams were generated
using the program MOLMOL (47).
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and B), the maximum increase (or decrease) in current during
the 1-s application of the peptide (Fig. 9, A and C), and the
change in reversal potential caused by application of the pep-
tide (Fig. 9D). In a separate series of experiments we also
measured the off rate for peptide dissociation from the chan-
nels at 30 mV (Fig. 9E).
At potentials in the range 20 mV to 30 mV, we fitted a
single exponential to the increase in current to obtain apparent
on rates (Fig. 9A, panels a and b). At 20 mV there were two
phases to the change in current during application of S5P
peptide, i.e. an initial increase in current followed by a slower
decrease in current. We fitted single exponential functions to
both phases; in the example shown in Fig. 9A (panel b), the
time constant for the initial increase was 89 ms, and the time
constant for the subsequent decrease was 1.4 s. To obtain the
time constant for the apparent on rate at more negative poten-
tials, it was necessary to correct for channel deactivation (see
“Experimental Procedures”). In the example illustrated in Fig.
9A (panel c), the time constant of deactivation in the control
trace (no peptide present) was 223 ms, and the time constant of
current decline following application of the S5P peptide was 65
ms. Substituting these values into Equation 3 gives an appar-
ent time constant for peptide binding of 92 ms, which is very
similar to that obtained by dividing the two current traces (88
ms; as shown in Fig. 9A, panel c, inset). For voltages in the
range 30 to 10 mV, the apparent time constant for peptide
binding, 100 ms, did not vary with voltage (Fig. 9B). How-
ever, in the voltage range 20 to 80 mV, the apparent time
constant for peptide binding decreased significantly as the
voltage became more negative (decreasing from 905  59 ms at
30 mV to 47  8 ms at 80 mV).
We measured the maximum increase (at potentials 	 20
mV) and decrease (at potentials 
 20 mV) in current during
application of the S5P peptide from the single exponential
curves fitted to the data after correcting for channel deactiva-
tion if appropriate (Fig. 9A, panel c, inset). The maximum
change in current during a 1-s application of 100 M S5P
peptide varied significantly with voltage. Note that the de-
crease at 70 mV (113  8%) was over 100%, indicating that
the current had reversed from an outward to an inward
current.
To estimate the change in reversal potential, we fitted single
exponentials to the decaying phase of currents recorded in the
voltage range 60 to 90 mV and extrapolated the fits back to
the start of the test voltage step (Fig. 9D). In the example
illustrated in Fig. 9D, the reversal potential changed from 80
to 64 mV. The mean change in reversal potential was from
83  1.5 mV (normal Tyrode solution) to 68  2.2 mV (in
the presence of S5P peptide, n  6). From the change in
reversal potential following application of S5P peptide, we es-
timate, using Equation 1, that the permeability ratio for K
over Na (PK/PNa) was reduced from 188  38 to 27  5 (n  6).
To estimate the off rate for peptide dissociation from the
channels at30 mV, we depolarized cells to30 mV, and after
1 s (when a steady-state current had been reached) we spritzed
on the peptide for 1 s and then maintained the cell at 30 mV
for a further 3 s (Fig. 9E). In the example illustrated in Fig. 9E,
the time constant for the increase in current in the presence of
S5P peptide was 123 ms, and the time constant of the decrease
in current following wash-off of the peptide was 2.26 s. The
time constant for wash-off, 2.06  0.56 s (n  4), was consid-
effect of S5P peptide (  17.8 s,   0.056 s1) and the wash off of the
S5P peptide effect (  53.7 s, k1  0.019 s
1). D, dose dependence of
effects of S5P peptide on currents recorded at 120 mV (n  3–4 at
each dose), using the protocol shown in A. The IC50 was obtained by
fitting a Hill function to the mean data.
FIG. 6. A, typical example of ion currents recorded from a CHO-
HERG cell during a step depolarization to 40 mV for 0.5 s followed by
a step to 120 mV. At a holding potential of 80 mV, channels are in
the closed state (C). During the step to 40 mV channels open (O)
slowly but inactivate (I) rapidly resulting in little current flow (thin
line). During the step to 120 mV, the channels rapidly recover from
inactivation (on the time scale of ms), resulting in a large increase in
current (thick line), and then deactivate slowly (on the time scale of tens
to hundreds of ms), resulting in a decay in current (dashed line) back to
the zero current level (indicated by dotted horizontal line at the left of
the trace). The dotted box on the voltage protocol shows the region of the
traces depicted in B. B, typical example of currents recorded from a
CHO-HERG cell using the voltage protocol shown in A before (i), after
1 min superfusion with 1 M S5P peptide (ii), and 6 min after washout
of the peptide (iii). The horizontal dotted line shows the zero current
level. The dotted vertical arrow indicates the point at which tail cur-
rents at 120 mV were measured (see C). C, changes in peak tail
current recorded at 120 mV prior to superfusion, during superfusion,
and following washout of 1 M S5P peptide. The peptide was applied for
1 min (shown by the solid bar at the top of the graph). The labels (i), (ii),
and (iii) indicate the time points for which traces are shown in B. The
thin lines show single exponential fits to the data for the onset of the
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erably shorter at 30 mV than was seen using the protocol in
Fig. 6, where the time constant for wash-off was 42  9 s (n 
4; see above). This suggests that dissociation of the peptide
from the channels is voltage-dependent. Substitution of the
time constants measured at30 mV into Equation 2 yielded an
on rate of 5.5  104 M1 s1 and a peptide affinity of 8.9  2.2
M (n  4).
The above results, most notably the altered ionic selectivity,
suggest that the exogenously applied S5P peptide is interacting
either directly with the selectivity filter of the channel or bind-
ing to the channel in such a way as to cause a change in the
conformation of the selectivity filter. To determine which re-
gion of the S5P peptide was responsible for the interaction with
the pore region of the HERG channel, we synthesized two
additional peptides. In the first peptide the amphipathic helix
was deleted and replaced with a (GGGS)3 linker (del-helix
peptide), and in the second the N- and C-terminal regions were
deleted, leaving just the amphipathic helix with four residues
at either side (helix peptide). All three peptides, S5P, del-helix,
and helix peptides, adopted a random coil conformation in
aqueous solution at pH 7.0 (Fig. 10A). In the presence of SDS
micelles, the del-helix peptide remained in a random coil con-
formation, and the S5P peptide contained some -helical ele-
ments (the spectra obtained at pH 3.0 (Fig. 2) and pH 7.0 (Fig.
10A) were indistinguishable), and the helix peptide adopted an
almost pure -helix, as expected. Typical examples of HERG
tail currents recorded at 80 mV during control sweeps or
during application of the S5P, del-helix, or helix peptides are
shown in Fig. 10B. Application of the del-helix peptide had no
significant effect on HERG currents. The helix peptide, how-
ever, had a very similar effect to that observed with the full-
length S5P peptide (also see below).
Typical examples of the effects of the helix peptide on HERG
tail currents recorded at 0, 40, and 80 mV (using the same
voltage protocol as shown in Fig. 7A) are illustrated in Fig. 11.
Application of 100 M helix peptide resulted in increased cur-
rent at 0 mV, a decreased current at 40 mV, and a clear
reversal of current flow at 80 mV (Fig. 11A). The apparent
time constants for helix peptide binding to the HERG channel
are plotted in Fig. 11B, and the maximal increase (at poten-
tials 	 20 mV) and decrease (at potentials -20 mV) in
current observed during 1 s of application of 100 M helix
peptide are shown in Fig. 11C. Qualitatively, the effects seen
with application of the helix peptide are very similar to those
seen with the S5P peptide (compare Figs. 9 and 11). There
were, however, some significant differences. The apparent time
FIG. 7. A, a typical example of a family
of currents recorded during a double
pulse protocol to examine the voltage de-
pendence of S5P peptide effects on HERG
channels. The cell was depolarized from a
resting membrane potential of 80 to
40 mV for 500 ms and then stepped to
potentials in the range 30 to 110 mV
for 2 s. The channels were deactivated by
hyperpolarizing the cell to 120 mV for
800 ms, and the protocol was repeated
except that during the second test pulse
100 M S5P peptide was applied for 1 s (as
indicated by the solid bar). The cell mem-
brane potential was then held at 80 mV
for 53 s between each sweep. The thick
lines show the current traces recorded for
the 30 mV test pulse (solid arrows) and
50 mV test pulse (dotted arrows). The
addition of peptide caused a significant
increase in current at 30 mV but a
marked suppression of current at 50
mV. The horizontal dotted line indicates
zero current. B, a typical example of the
mean  S.E. of the current recorded dur-
ing five successive sweeps at 60-s inter-
vals where the test step was 70 mV for
all five sweeps. The voltage protocol is
illustrated above the current trace, and
the dotted boxes (thin, control; thick, with
S5P peptide) indicate the regions that are
plotted. 100 M S5P peptide was applied
for 1 s as indicated by the thick line in the
voltage protocol. The effect of the peptide
was reproducible (as indicated by the
small error bars) and the effect of the
peptide washed off within 60 s. The hori-
zontal dotted line indicates the zero cur-
rent level. It is worth noting that the cur-
rent recorded at 70 mV in the presence
of the peptide reversed from an outward
current to an inward current.
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constants for peptide binding were faster for the helix peptide
than for the S5P peptide (compare Figs. 9B and 11B), the off
rate was also slightly faster for the helix (time constant for
dissociation at 30 mV was 0.85  0.15 s (n  5) for the helix
peptide compared with 2.06  0.56 s (n  4) for the S5P
peptide), and the maximum increase in current seen at positive
potentials was less for the helix peptide than for S5P peptide
(Table I). However, the shift in the reversal potential (14  2
mV, n  4) following addition of the helix peptide was similar
to that seen with the S5P peptide (16  2 mV, n  6). The
del-helix peptide, 100 M, had no effect on the reversal poten-
tial of HERG currents and caused no increase in current at
positive potentials; rather it caused a very modest decrease in
current at all potentials (Table I).
The shift in reversal potential following application of either
the 42-residue S5P peptide or the 19-residue helix peptide was
consistent with a decreased selectivity for K over Na. To
further investigate this possibility we looked at the effects of
both peptides when all external Na was replaced with
NMDG. In the absence of external Na, acute application of
either the S5P peptide or the helix peptide caused only modest
decreases in current at all test potentials (Fig. 12A). Further-
more there was no current reversal at 80 mV following ap-
plication of either peptide in NMDG solutions. It should be
noted, however, that both the S5P and helix peptides caused
inhibition of current at 120 mV when applied for 1 min in
NMDG external solutions (Fig. 12B). This confirms that the
peptide was still active, but either its apparent affinity was
much reduced or the effect it has on the channel was substan-
tially altered in the absence of external Na.
DISCUSSION
The S5P Linker Contains an Amphipathic Helix—In this
work we have identified an amphipathic -helix that is present
in the extracellular linker connecting the outer ends of S5 and
the pore helix of the HERG K channel. The 42-residue peptide
spanning this region is unstructured in aqueous medium but
contains -helical elements when in the presence of SDS mi-
celles. The major helical element extends from Trp585 to Ile593
(WLHNLGDQI; Fig. 5) and has a well defined hydrophobic
face. Interestingly, this helix contains a glycine, Gly590, which
in the center of a helix usually has a destabilizing effect (51). It
is possible that the presence of the glycine is the reason that
the S5P peptide is unstructured in water. It appears that an
interaction between the hydrophobic surface of the helix and
the hydrocarbon chains of the SDS stabilizes the helix in vitro.
In vivo and in the native protein, the stabilizing force may be
provided by the helix interacting with the membrane or with
other parts of the protein.
The amphipathic -helix we have identified (Trp585–Ile593)
corresponds closely with the predictions originally made by
Pardo-Lopez et al. (23), based on the effects of cysteine scan-
FIG. 8. Typical examples of the ef-
fect of 100 M S5P peptide applied for
1 s on HERG currents recorded dur-
ing test potential steps in the range
30 to 110 mV. The dotted boxes (thin,
control; thick, with S5P peptide) on the
voltage protocol indicate which regions
are shown in the current traces. Applica-
tion of S5P peptide resulted in increased
current at depolarized potentials (at least
20 mV), a more rapid decline in current
at intermediate potentials (30 to 60
mV), and a reversal of current from out-
ward to inward at 70 and 80 mV. At
the most negative voltages the peptide
had little observable effect on the current.
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FIG. 9. A, typical examples of current traces (control, thin trace; with S5P peptide, thick trace) obtained for test pulses of 30 mV (panel a),
20 mV (panel b), and70 mV (panel b, taken from the same cell as used in Fig. 8). The effect of S5P peptide on HERG currents was quantified
by fitting single exponential functions (thin lines superimposed on current traces) to the ascending (denoted by open boxes) or descending
(denoted by closed box) portions of the currents recorded during application of S5P peptide. In panel a, the onset of the current increase in the
presence of S5P peptide had a time constant of 123 ms, and in panel b, the time constant was 89 ms. At 20 mV the current subsequently
decreased in the continued presence of peptide with a time constant of 1.4 s. At 70 mV the exponential fit to the decrease in current had a
time constant of 65 ms. This time constant represents a composite of the time constants of deactivation (223 ms, measured in the corresponding
control current trace) and peptide binding. The apparent peptide binding time constant was obtained by dividing the current recorded in the
presence of peptide (IS5P) by the control current (Icon; see inset; also see text for details of method used to deconvolve time constants). The inset
also highlights how we calculated the maximum decrease in current for test potentials in the range 30 to 70 mV. In this example the
maximum decrease was 140%, indicating that the current had reversed from outward to inward. B, the means  S.E. for the time constants
measured from the ascending phase (open symbols, n  4) and descending phase (after correction for deactivation; closed symbols, n  5) of
currents following addition of S5P peptide. There were no significant differences between the time constants measured at positive potentials
(analysis of varianne). Time constants at voltages in the range 70 to 30 mV were significantly different from each other. C, summary of
the maximum change (increase at positive potentials (open symbols) or decrease at potentials 
 20 mV (closed symbols)) in current following
application of 100 M S5P peptide (mean  S.E., n  4–5). Note there are two points for 20 mV reflecting the fact that the current initially
increased but subsequently decreased in the presence of the peptide at this voltage. D, typical examples of current traces recorded at 70, 80,
and 90 mV during control conditions and 60, 70, and 80 mV in the presence of S5P peptide. The reversal potential was calculated from
the extrapolated current at the start of the test pulse. Extrapolations were obtained by fitting a single exponential to the slow decaying phase
of the current. In this example the reversal potential was shifted from 80 to 64 mV during addition of the S5P peptide. E, typical examples
of currents recorded at 30 mV during application and wash-off of 100 M S5P peptide (indicated by a thick bar above the voltage protocol).
Thin lines show single exponential fits used to obtain time constants for the apparent binding (123 ms) and wash-off (2.26 s) of the peptide.
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ning mutagenesis on ErgToxin binding to the HERG K chan-
nel. Therefore, the amphipathic helix we have identified in the
isolated peptide is almost certainly present in the intact pro-
tein as well.
Two pieces of evidence support the suggestion that the am-
phipathic -helix interacts with another part of the HERG
protein. First, in the ensemble of the 20 lowest energy struc-
tures, the hydrophobic residues Trp585, Leu586, and Leu589 are
contained within a region that is very tightly constrained (root
mean square deviation for the side chain heavy atoms of resi-
dues WLHNL in the peptide was 0.23 Å). Furthermore these
hydrophobic residues are 100% conserved in all members of the
ERG/EAG/ELK channel family (Fig. 1), whereas there is much
less conservation among the hydrophilic residues. The conser-
vation of sequence as well as the tight structural constraints
argues in favor of the hydrophobic surface, representing a
region of specific protein-protein interaction. Second, applica-
tion of exogenous S5P peptide to wild type HERG K channels
caused dramatic changes in channel properties (see below).
The Amphipathic Helix Interacts with the Pore Region of the
Channel—Exogenous application of the S5P peptide had at
least two effects on HERG currents. First it suppressed the
current (Figs. 6 and 12B). Second, it appeared to disrupt inac-
tivation (e.g. it caused an increased current flow at positive
potentials; Fig. 8) and reduced the selectivity for K over Na
(Fig. 9D). We have classed the last two effects together because
it is likely that they are related (see below). Furthermore, these
effects were also seen following superfusion of CHO-HERG
cells with the helix peptide that corresponded to residues
Ser581–Ser599 but not with a peptide in which the amphipathic
-helix was replaced with a (GGGS)3 linker. Thus it seems that
the major site of interaction between the S5P peptide and the
rest of the channel involves the amphipathic -helix.
Current Suppression—When cells were exposed for pro-
longed periods to S5P peptide, current was suppressed in a
dose-dependent manner with an IC50 of1.9 M (Fig. 6D). This
inhibitory effect of the S5P peptide was independent of external
Na (Fig. 12B); however, in the absence of external sodium, the
potency of the peptide appeared to be much reduced. For ex-
ample 100 M peptide only caused 60% inhibition after 1 min
in cells superfused with Na-free solution (Fig. 12B), but93%
inhibition after 10 s in cells superfused with Na-external
solution (Fig. 6D).
Disrupted Inactivation and Altered Selectivity—The addition
of 100 M S5P peptide to HERG K channels caused a depo-
larizing shift in the reversal potential by 16  2 mV (Fig. 9D
and Table I). However, when all external Na was replaced by
NMDG, the S5P peptide no longer caused a shift in reversal
potential (Table I). These results indicate that the channels
had a decreased selectivity for K over Na. If a decrease in
selectivity for K relative to Na was the only effect of acute
application of S5P peptide, then one would not have expected
an increase in current at positive voltages (Fig. 8, panels a–c),
because the positive shift in reversal potential would result in
a smaller driving force for outward current flow. The relatively
small current flow through HERG K channels at positive
potentials is due to rapid voltage-dependent inactivation (1,
10–12). Thus one possibility is that in addition to altering the
selectivity of the channels, the peptide has altered inactivation.
Such a hypothesis is also consistent with previous reports
showing that many of the mutations in the S5P linker that
affect inactivation also affect the selectivity for K over Na
(19). The association between disruption in inactivation and
changes in ionic selectivity is one of the strongest pieces of
evidence supporting the “collapse of the pore” model of inacti-
vation in HERG K channels (3). Thus we suggest that the
exogenously applied S5P peptide either itself directly binds to
the pore region and thereby disrupts inactivation and K-Na
selectivity, or it binds to the outer pore region in such a way
that it induces a conformational change in the selectivity filter
region.
The very significant reduction in the effect of acute applica-
tion of S5P peptide when external Na was replaced by
NMDG (compare Figs. 9 and 12) suggests that the increase in
current seen with application of S5P peptide at positive poten-
tials is Na-dependent. Previous work from Balser and col-
leagues (52) has shown that inactivation of HERG K channels
is promoted by extracellular Na. Thus it may be that the S5P
peptide is competing with external Na for binding to the site
that when occupied by Na promotes inactivation (52).
FIG. 10. A, far-UV CD spectropolarimetry spectra for S5P peptides.
All three peptides display a predominantly random coil conformation in
aqueous environment (thin lines) with little evidence for secondary
structure. However, in the presence of SDS micelles (thick lines) both
the S5P peptide and the helix peptide display elements of helical struc-
ture, whereas the del-helix remains unstructured. Calculation of the
mean residue molar ellipticity, which takes into account the number of
peptide bonds in the peptide, indicates that the helix peptide is almost
completely helical in SDS micelles, with very little of the sequence in
alternative conformations, whereas the S5P contains significant ran-
dom coil content in addition to the helical elements. This is consistent
with the experimentally determined structure of the S5P peptide and
what would be expected from secondary structure prediction algo-
rithms. B, typical examples of HERG currents recorded at 80 mV test
potentials under control conditions (thin traces) and following addition
of peptides (thick traces). S5P peptide causes a shift to inward current,
the del-helix peptide has minimal effect on the current and the helix
peptide has a similar effect to the full-length peptide. The dotted line in
each trace indicates the zero current level.
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Is Binding of S5P to the HERG K Channel Voltage-depend-
ent?—The effect of the acute application of S5P peptide to
HERG K channels was clearly voltage-dependent (Figs. 8 and
9). The voltage dependence of the time constants for change in
current following addition of S5P peptide (Fig. 9B) also sug-
gests that there are two components to peptide binding. First,
at positive potentials the time constant of current increase (Fig.
9B, open symbols) is rapid and voltage-independent. Second, at
potentials in the range 20 to 80 mV, the time constant for
the decrease in current (Fig. 9B, closed symbols) is voltage-de-
pendent. It should be noted that in our analysis of the apparent
on rates at negative voltages, we assumed that the effect of
peptide binding to the channels was independent of deactiva-
tion (see “Experimental Procedures” and Fig. 9A). This is the
simplest model that is consistent with the data that we have;
however, we cannot assume that the model is necessarily cor-
rect. If our assumption regarding independence of peptide
binding and deactivation is incorrect, then it is possible that
part of the “voltage dependence” of the time constants in the
voltage range 20 to 80 mV seen in Fig. 9B may reflect the
voltage dependence of the rates of deactivation in this voltage
range rather than voltage dependence of binding per se. Con-
versely, the off rate measured at30 mV (a voltage at which no
deactivation was observed) was considerably faster (0.48 s1;
Table I) than the off rate measured from Fig. 6C (0.024 s1)
when cells were held at 80 mV between pulses. From these
values the calculated on rates were 5.5  104 M1 s1 at 30
mV and 2.1  104 M1 s1 at -80 mV. Thus we can conclude
that there is a voltage-dependent component to peptide binding
and that the off rate appears to be more voltage-sensitive than
the on rate. However, the precise influence of voltage on pep-
tide binding in the voltage range 20 to 80 mV remains to be
determined.
The augmentation of current at positive potentials but inhi-
bition at negative potentials following application of the S5P
peptide (Fig. 9C) is reminiscent of the effect of Ba2 on HERG
K channels (53), i.e. 2 mM Ba2 blocks HERG currents at
negative voltages but increases the current at positive voltages,
an effect that has been attributed to a voltage-dependent com-
petition between Ba2 and Na for binding to an outer pore-
binding site (52). Although the voltage protocols used in the
earlier Ba2 studies (52, 53) and this study are different, it is
possible that the S5P peptide, like Ba2, may be competing
with Na for binding to an outer pore-binding site and that this
competition is voltage-dependent. The significant change in the
effect of the peptides on HERG channels when external Na
was replaced with NMDG also supports the hypothesis that
the peptide is competing with external Na for binding to an
outer pore-binding site.
Comparison of the Effects of the S5P Peptide and the Helix
Peptide—The effects of adding the S5P peptide to HERG chan-
nels could be reproduced, qualitatively, with a 19-residue pep-
tide containing only the amphipathic helix and four flanking
residues on either side. There were, however, some quantita-
tive differences in the effects of the two peptides on HERG
channels. First, the amphipathic helix appears to bind more
rapidly. For example the time constant for binding of 100 M
peptide at 0 mV was 145  36 ms (n  5) for S5P peptide
compared with 36 7 ms (n 3) for the helix peptide (Table I).
Second, the maximum increase in current seen during peptide
application at positive potentials was greater for the S5P pep-
tide than for the helix peptide. For example the maximum
increase at 30 mV was 56  22% (n  4) for the S5P peptide
and 9  3% (n  3) for the helix peptide (Figs. 9C and 11C and
Table I). These data suggest that a region of the S5P peptide
not present in the helix peptide, for example the charged motif
TABLE I
Summary of effects of S5P, helix, and del-helix peptides on
HERG current
For the S5P and helix peptides, the measurements are from n  4–6
cells, and for the del-helix peptide, the measurements are from n  3
cells. ND, not determined.
S5P peptide Helix peptide Del-helix peptide

 Erev (mV) 16  2 14  2 0.7  0.3
a
on (30 mV) (ms) 168  35 27  6
b 1630  200a
off (30 mV) (s) 2.06  0.6 0.85  0.15
b ND

 I(30 mV) (%) 56  22 9  3
b 9  4a
on (0 mV) (ms) 145  32 36  7
b 890  140a

 I(0 mV) (%) 40  8 33  3 11  3
a
on (60 mV) (ms) 99  9 71  17
b 2550  440a

 I(60 mV) (%) 71  9 70  10 21  5
a
a Significantly different between del-helix peptide and S5P and helix
peptides.
b Significantly different between S5P and helix peptides.
FIG. 11. A, typical examples of the ef-
fect of 100 m helix peptide applied for 1 s
(denoted by solid bar on voltage protocol)
on HERG tail currents recorded during
voltage steps to 0, 40, and 80 mV. The
control traces are shown using thin lines,
and the peptide traces are shown using
thick lines. The horizontal dotted lines in-
dicate the zero current level. B, summary
of the time constants for increases in cur-
rent (open symbols) and decreases in cur-
rent (closed symbols) following applica-
tion of the peptide (mean  S.E., n  4)
analyzed as described in the legend to
Fig. 9B. C, maximal percentage change in
current (open symbols, increase in current
for voltage range 30 to 20 mV; closed
symbols, decrease in current for voltage
range 20 to 70 mV) following the ad-
dition of 100 M helix peptide (mean 
S.E., n  4), analyzed as described in the
legend to Fig. 9C. The error bars are in
general smaller than the size of the
symbols.
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at the C-terminal end, inhibits access of the amphipathic helix
to a binding site on the channel. However, once it has bound the
S5P peptide is more effective than the helix peptide at altering
channel function. Whether such differences are of physiological
significance, however, are debatable given that in the native
channel movement of the amphipathic helix is likely to be
constrained by its attachments to the S5 and pore helices.
How Does the S5P Peptide Interact with the Rest of the HERG
Channel?—Given that the S5P linker is critical for inactivation
of HERG K channels and inactivation in HERG K channels
is voltage-dependent (1, 10–12), it is possible that voltage-de-
pendent binding of the S5P linker to the outer pore of the
channel could contribute to the voltage-dependent inactivation
of HERG K channels. There are a number of charged residues
in the S5P linker including an aspartate (Asp591) in the am-
phipathic -helix (Fig. 1) that in theory could contribute to
voltage-dependent binding of the S5P linker to the rest of the
channel. The observation that mutation of Asp591 to a cysteine
disrupts inactivation of HERG K channels (19) suggests that
this residue may be important for binding of the amphipathic
helix to the rest of the channel, but whether it could contribute
to voltage-dependent binding of the amphipathic helix to the
pore region of the channel has not been tested.
We were not able to define a unique three-dimensional fold
for the S5P loop of the HERG K channel, despite constraining
the ends of the peptide to the homologous residues in the KcsA
structure (22). This result is consistent with the NMR spectros-
copy data, however, showing that significant stretches of the
linker, Ala571–Gly584 and Gly594–Gly603, may be highly flexible.
Flexibility in this region could be advantageous in that it may
allow significant movement of the amphipathic -helix, which
has been suggested to occur during inactivation (19). To further
address this issue will require additional experimental data to
help constrain the possible orientations of the S5P linker and to
identify the specific site(s) of interaction between the S5P
linker and the rest of the channel. Such data could be provided
by mutant cycle analysis experiments analogous to those used
to identify the sites of interaction between the scorpion toxin
BeKm-1 and the outer vestibule of the HERG K channel (54).
In summary, we have provided the first structural informa-
tion on the outer pore region of the HERG K channel, a region
that is critical for the rapid inactivation of the channel (19, 24).
This unique feature of the HERG K channel is essential for its
function in normal cardiac repolarization. We have also shown
that the S5P peptide is able to interact with the rest of the
HERG channel, resulting in suppression of current, an altered
selectivity for K over Na, and partial disruption of inactiva-
tion. Furthermore, we have shown that it is the amphipathic
-helix region that is critical for the effects on ion selectivity
and inactivation, because when the amphipathic -helix region
of the S5P peptide is replaced with a random coil linker, the
peptide no longer affects ion selectivity or inactivation (Fig.
10B and Table I), whereas a peptide containing only the helix
region has very similar effects on the HERG channels as the
full-length peptide (compare Figs. 9 and 11). Interestingly, the
S5P peptide and the helix peptide are able to affect HERG
channels despite being applied in normal Tyrode solution
where in isolation they would be expected to have a random coil
conformation. Presumably, however, the peptides are able to
form helices in the context of the HERG K channels and the
associated membrane environment.
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Supplementary data – Structural statistics for the NMR data
Table S1 Proton chemical shifts of S5-P in SDS at pH 3.3 and 303K1
Residue NH CaH CbH CgH Others
Ala1 - 4.24 1.57
Ile2 8.39 4.13 1.91 CgH3  0.97 CdH3 0.92
CgH2  1.25,1.57
Gly3 8.27 3.93
Asn4 8.16 4.76 2.76,2.90 NdH2 6.82,7.53
Nle5 7.97 4.21 1.82 1.41 CdH2 1.34 CeH3 0.90
Glu6 7.96 4.39 1.98,2.12 2.46
Gln7 8.06 4.45 1.97,2.03 2.32 NeH2 6.72,7.46
Pro8 - 4.46 2.02,2.28 1.87,1.96 CdH2 3.66,3.78
His9 8.37 4.77 3.24,3.30 C(2)H 8.62; C(4)H 7.37
Nle10 8.11 4.17 1.81 1.34 CeH3 0.89
Asp11 8.44 4.59 2.93
Ser12 8.07 4.45 3.94
Arg13 8.10 4.41 1.93 1.7 CdH2 3.07,3.12; NeH 7.12
Ile14 7.76 4.05 1.89 CgH3 0.86 CdH3 0.81
CgH2 1.22,1.49
Gly15 8.34 3.93,4.04
Trp16 7.77 4.41 3.38,3.43 C(2)H 7.37; N(1)H 9.96
C(7)H 7.41; C(6)H 7.06
C(5)H 6.96; C(4)H 7.42
Leu17 7.76 3.90 1.49,1.54 1.58 CdH3 0.81,0.89
His18 8.04 4.40 3.29,3.34 C(2)H 8.64; C(4)H 7.35
Asn19 8.06 4.57 2.77,2.88 NdH2 6.86,7.46
Leu20 7.81 4.12 1.65 1.60 CdH3 0.84
Gly21 8.35 3.78,3.94
Asp22 7.93 4.60 2.96
Gln23 8.05 4.33 2.12,2.23 2.41 NeH2 6.72,7.31
Ile24 7.68 4.16 1.97 CgH3 0.98 CdH3 0.89
CgH2 1.26,1.59
Gly25 8.02 3.90,3.94
Lys26 7.83 4.54 1.72,1.74 1.44,1.46 NzH3+ 7.43
Pro27 4.44 1.86,2.24 1.96 CdH2 3.63,3.78
Tyr28 7.83 4.53 3.02 C(3,5)H 6.81; C(2,6)H 7.08
Asn29 8.12 4.70 2.72,2.84 NdH2 6.85,7.54
Ser30 8.12 4.41 3.87,4.00
Ser31 8.27 4.44 3.95
Gly32 8.20 3.95,4.03
Leu33 8.00 4.36 1.64,1.71 1.60 CdH3 0.89,0.94
Gly34 8.20 3.98
Gly35 8.06 4.09
Pro36 - 4.46 2.32 1.96,2.04 CdH2 3.64,3.69
Ser37 8.17 4.48 3.92,3.97
Ile38 8.08 4.04 2.03 CgH3 1.00 CdH3 0.95
CgH2 1.31,1.63
Lys39 8.01 4.09 1.80,1.85 1.45,1.51 CdH2 1.72; CeH2 3.01
NzH3+ 7.43
Asp40 7.88 4.62 2.93
Lys41 7.76 4.16 1.61,1.70 1.12,1.26 CdH2 1,62; CeH2 2.95
NzH3+ 7.41
Tyr42 7.67 4.68 2.84,3.16 C(3,5)H 6.79; C(2,6)H 7.12
1 Proton chemical shifts
Table S2 Structural statistics for the ensemble of 20 S5-P structures in presence
of SDS micelles
Distance restraints
Intraresidue (i–j = 0) 189
Sequential (|i–j| = 1) 153
medium-range (|i–j|!£ 5)   74
long-range (|i–j|!>!5)    0
hydrogen-bonds 14
Total 430
Atomic rms differences (Å)1 versus mean pairwise
backbone atoms (14-24) 0.31!±!0.12 0.44 ± 0.17
heavy atoms (14-24) 0.73!± 0.13 1.02 ± 0.22
backbone atoms (35-42) 0.23!±!0.07 0.31 ± 0.13
heavy atoms (35-42) 0.68± 0.16 0.95 ± 0.23
1Atomic differences given as average rms difference against mean coordinate structure (mean) and
average rms difference of all pairwise structures (pairwise). Values given as mean ± SD.
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